VCP
DGX icon

Verus Capital Partners’s Quest Diagnostics DGX Stock Holding History

Verus Capital Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$24K Buy
301
+271
+903% +$28.1K 0.01% 743
2019
Q4 		$3K Buy
+30
New +$3.13K ﹤0.01% 1369

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Verus Capital Partners's DGX Position: Q1 2020 in Review

Verus Capital Partners increased its Quest Diagnostics (DGX) stake by 903% in Q1 2020, buying an estimated $28.1K and bringing the position to 301 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #743.

Verus Capital Partners first reported a position in DGX in Q4 2019 and has held it in 2 quarters since. 714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

  • Verus Capital Partners held 301 shares of Quest Diagnostics worth $24K as of Q1 2020.
  • Verus Capital Partners bought 271 Quest Diagnostics shares in Q1 2020, an estimated $28.1K.
  • Quest Diagnostics made up 0.01% of Verus Capital Partners's portfolio in Q1 2020, its #743 holding.
  • Verus Capital Partners first reported a position in Quest Diagnostics in Q4 2019 and has held it in 2 quarters since.
  • 714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.